Low concentrations of Bisphenol A induce mouse spermatogonial cell proliferation by G protein-coupled receptor 30 and estrogen receptor-α

Environmental Health Perspectives

Volumn 119, Issue 12, 2011, Pages 1775-1780

  Sheng, Zhi Guo ^a   Zhu, Ben Zhan ^a,b  

^a RESEARCH CENTER FOR ECO ENVIRONMENTAL SCIENCES   (China)

^b OREGON STATE UNIVERSITY   (United States)

Author keywords

17 estradiol; Bisphenol A; Estrogen receptor ; G protein coupled receptor 30; Mouse spermatogonial GC 1 cells

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; G PROTEIN COUPLED RECEPTOR 30; MITOGEN ACTIVATED PROTEIN KINASE; RETINOBLASTOMA PROTEIN;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; FOS GENE; GENE; GENE ACTIVATION; GENE FUNCTION; GENE SILENCING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REACTION TIME; REPORTER GENE; REPRODUCTIVE TOXICITY; SIGNAL TRANSDUCTION; SPERMATOGONIUM; TRANSACTIVATION;

EID: 82755162807     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1103781     Document Type: Article

References (35)

1. Albanito L, Lappano R, Madeo A, Chimento A, Prossnitz ER, Cappello AR, et al. 2008a. G-protein-coupled receptor 30 and estrogen receptor-α are involved in the proliferataive effects induced by atrazine in ovarian cancer cells. Environ Health Perspect 116:1648-1655.
2. Albanito L, Madeo A, Lappano R, Vivacqua A, Rago V, Carpino A, et al. 2007. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17β estradiol and selective GPR30 ligand G-1 in ovarian cancer cells. Cancer Res 67:1859-1866.
3. Albanito L, Sisci D, Aquila S, Brunelli E, Vivacqua A, Madeo A, etal. 2008b. Epidermal growth factor induces G protein coupled receptor 30 expression in estrogen receptor negative breast cancer cells. Endocrinology 149:3799-3808.
4. Atanaskova N, Keshamouni VG, Krueger JS, Schwartz JA, Miller F, Reddy KB. 2002. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance. Oncogene 21:4000-4008.
5. Belcher SM, Le HH, Spurling L, Wong JK. 2005. Rapid estrogenic regulation of extracellular signal-regulated kinase 1/2 signaling in cerebellar granule cells involves a G proteinand protein kinase A-dependent mechanism and intracellular activation of protein phosphatase 2A. Endocrinology 146:5397-5406.
6. Bellvé AR, Cavicchia JC, Millette CF, O'Brien DA, BhatnagarYM, Dym M. 1977. Spermatogenic cells of the prepuberal mouse: isolation and morphological characterization. J Cell Biol 74:68-85.
7. Bonefeld-Jørgensen EC, Andersen HR, Rasmussen TH, Vinggaard AM. 2001. Effect of highly bioaccumulated polychlorinated biphenyl congeners on estrogen and androgen receptor activity. Toxicology 158:141-153.
8. Bouskine A, Nebout M, Brücker-Davis F, Benahmed M, Fenichel P. 2009. Low doses of bisphenol A promote human seminoma cell proliferation by activating PKA and PKG via a membrane G-protein-coupled estrogen receptor. Environ Health Perspect 117:1053-1058.
9. Bulayeva NN, Watson CS. 2004. Xenoestrogen-induced ERK-1 and ERK-2 activation via multiple membrane-initiated signaling pathways. Environ Health Perspect 112:1481-1487.
10. Bunone G, Briand PA, Miksicek RJ, Picard D. 1996. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J 15:2174-2183.
11. Coulon V, Chebli K, Cavelier P, Blanchard JM. 2010. A novel mouse c-fos intronic promoter that responds to CREB and AP-1 is developmentally regulated in vivo. PLoS One 5:e11235; doi:10.1371/journal.pone.0011235 [Online 21June 2010].
12. Filardo EJ. 2002. Epidermal growth factor receptor (EGFR) transactivation by estrogen via the G-protein-coupled receptor, GPR30: a novel signaling pathway with potential significance for breast cancer. J Steroid Biochem Mol Biol 80:231-238.
13. Filardo EJ, Quinn JA, Bland KI, Frackelton AR Jr. 2000. Estrogen induced activation of Erk-1 and Erk-2 requires the G proteincoupled receptor homolog, GPR30, and occurs via transactivation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol 14:1649-1660.
14. Filardo EJ, Quinn JA, Frackelton AR Jr., Bland KI. 2002. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol Endocrinol 16:70-84.
15. Gaskell TL, Robinson LL, Groome NP, Anderson RA, SaundersPT. 2003. Differential expression of two estrogen receptor β isoforms in the human fetal testis during the second trimester of pregnancy. J Clin Endocrinol Metab 88:424-432.
16. Hirvonen-Santti SJ, Rannikko A, Santti H, Savolainen S, NybergM, Janne OA, et al. 2003. Down-regulation of estrogen receptor beta and transcriptional coregulator SNURF/ RNF4 in testicular germ cell cancer. Eur Urol 44:742-747.
17. Joel PB, Traish AM, Lannigan DA. 1995. Estradiol and phorbol ester cause phosphorylation of serine 118 in the human estrogen receptor. Mol Endocrinol 9:1041-1052.
18. Lannigan DA. 2003. Estrogen receptor phosphorylation. Steroids 68:1-9.
19. Levin ER. 2003. Bidirectional signaling between the estrogen receptor and the epidermal growth factor receptor. Mol Endocrinol 17:309-317.
20. Mayr B, Montminy M. 2001. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2:599-609.
21. Metzger D, Ali S, Bornert JM, Chambon P. 1995. Characterization of the amino-terminal transcriptional activation function of the human estrogen receptor in animal and yeast cells. J Biol Chem 270:9535-9542.
22. Pais V, Leav I, Lau KM, Jiang Z, Ho SM. 2003. Estrogen receptorbeta expression in human testicular germ cell tumors. Clin Cancer Res 9:4475-4482.
23. Pétrier C, Torres-Palma R, Combet E, Sarantakos G, Baup S, Pulgarin C. 2010. Enhanced sonochemical degradation of bisphenol-A by bicarbonate ions. Ultrason Sonochem 17:111-115.
24. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER. 2005. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307:1625-1630.
25. Richter CA, Birnbaum LS, Farabollini F, Newbold RR, Rubin BS, Talsness CE, et al. 2007. In vivo effects of bisphenol A in laboratory rodent studies. Reprod Toxicol 24:199-224.
26. Salian S, Doshi T, Vanage G. 2011. Perinatal exposure of rats to bisphenol A affects fertility of male offspring-an overview. Reprod Toxicol 31:359-362.
27. Schönfelder G, Wittfoht W, Hopp H, Talsness CE, Paul M, ChahoudI. 2002. Parent bisphenol A accumulation in the human maternal-fetal-placental unit. Environ Health Perspect 110:A703-A706.
28. Shaulian E, Karin M. 2002. AP-1 as a regulator of cell life and death. Nat Cell Biol 4:131-136.
29. Shaywitz AJ, Greenberg ME. 1999. CREB: a stimulus-induced transcription factor activated by a diverse array of extra-cellular signals. Annu Rev Biochem 68:821-861.
30. Sheng Z, Cao X, Peng S, Wang C, Li Q, Wang Y, et al. 2008. Ofloxacin induces apoptosis in microencapsulated juvenile rabbit chondrocytes by caspase-8-dependent mitochondrial pathway. Toxicol Appl Pharmacol 226:119-127.
31. Sirianni R, Chimento A, Ruggiero C, De Luca A, Lappano R, Andò S, et al. 2008. The novel estrogen receptor, G protein coupled receptor 30, mediates the proliferative effects induced by 17β-estradiol on mouse spermatogonial GC-1 cell line. Endocrinology 149:5043-5051.
32. Thomas P, Dong J. 2006. Binding and activation of the seven transmembrane estrogen receptor GPR30 by environmental estrogens: a potential novel mechanism of endocrine disruption. J Steroid Biochem Mol Biol 102:175-179.
33. Vandenberg LN, Chahoud I, Heindel JJ, Padmanabhan V, PaumgarttenFJ, Schoenfelder G. 2010. Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A. Environ Health Perspect 118:1055-1070.
34. Welshons WV, Nagel SC, vom Saal FS. 2006. Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology 147:S56-S69.
35. Wetherill YB, Akingbemi BT, Kanno J, McLachlan JA, Nadal A, Sonnenschein C, etal. 2007. Invitro molecular mechanisms of bisphenol A action. Reprod Toxicol 24:178-198.